This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 October 2024 and includes updates on measles, mpox, avian influenza, West Nile virus, dengue, Marburg virus disease, a new strain of multidrug-resistant Shigella Sonnei ST152, and an overview of respiratory virus epidemiology in the EU/EEA.
Since the beginning of 2024, and as of 1 October 2024, five MERS cases, including four fatalities, have been reported in Saudi Arabia with date of onset in 2024.
This focused after-action review (AAR) investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron variant was circulating and schools remained open.
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA).
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe disease in humans caused by Marburg marburgvirus (MARV). Although MVD is uncommon, MARV has the potential to cause epidemics with significant case fatality rates.
ECDC is helping countries in the Western Balkans and Türkiye improve their infectious disease prevention and control systems and public health workforce. This will prepare the countries for their future participation in ECDC work.
